Prevalence of programmed death ligand-1 in patients diagnosed with non-small cell lung cancer in Lebanon

INTRODUCTION: Programmed death ligand-1 expression has been shown to be a good predictor of response to cancer therapy with checkpoint inhibitors. Its expression varies among different tumor types and among non-small cell lung cancer patients with different clinical and demographic characteristics....

Descripción completa

Detalles Bibliográficos
Autores principales: Fakhri, Ghina, Akel, Reem, Khalifeh, Ibrahim, Chami, Hassan, Hajj Ali, Adel, Al Assaad, Majd, Atwi, Haneen, Kadara, Humam, Tfayli, Arafat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442479/
https://www.ncbi.nlm.nih.gov/pubmed/34540227
http://dx.doi.org/10.1177/20503121211043709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442479/
https://www.ncbi.nlm.nih.gov/pubmed/34540227
http://dx.doi.org/10.1177/20503121211043709

Ejemplares similares